Aidoc gets FDA nod for AI pulmonary embolism screening tool
The FDA decision, which builds on a prior approval of the company's algorithm for the detection of intracranial hemorrhages through CT scans, is part of a larger vision sketched out by CEO Elad Walach of plugging new algorithms into the Aidoc system to create a new standard of care in radiology.